Measuring the success of internal communications in pharma means tracking reach, comprehension, engagement, and behaviour change — not just open rates or email click-throughs. Effective measurement connects communication activity to outcomes that matter: whether employees understand key messages, act on them, and whether those actions align with your organisation’s compliance, scientific, and commercial priorities. The questions below unpack each dimension of that challenge in practical detail.
What metrics actually reflect internal comms effectiveness in pharma?
The metrics that genuinely reflect internal comms effectiveness in pharma go beyond surface-level analytics. Reach tells you who received a message; comprehension tells you who understood it; behaviour tells you who acted on it. In pharmaceutical organisations, all three layers matter — measuring only one gives a distorted picture of how well your communications are working.
Useful metrics fall into three broad categories:
- Reach and consumption: Open rates, intranet page views, video completion rates, and attendance at town halls or briefings. These are necessary baselines but insufficient on their own.
- Comprehension and retention: Quiz scores following training communications, recall rates in pulse surveys, and accuracy of message playback in focus groups or manager check-ins.
- Behavioural and business outcomes: Compliance audit results, policy adoption rates, cross-functional collaboration indicators, and employee-reported confidence in decision-making.
In pharma specifically, the stakes attached to comprehension are unusually high. A medical affairs team that misunderstands a product communication or a regulatory update can create real downstream risk. Pharma internal comms metrics need to be designed with that risk context in mind — not borrowed wholesale from consumer or retail communications benchmarks.
How do you measure employee engagement with internal communications?
Employee engagement with internal communications in pharma is best measured through a layered approach combining passive data, active feedback, and qualitative insight. No single data point captures engagement accurately. What looks like strong engagement on one channel may mask low comprehension or poor reach among specific functions or geographies.
Practical approaches include:
- Pulse surveys: Short, frequent surveys — monthly or quarterly — that ask employees whether communications feel relevant, clear, and timely. These are more actionable than annual engagement surveys because they allow faster course correction.
- Channel analytics: Intranet dwell time, email click-through rates, and video watch time indicate whether content is holding attention, not just being opened.
- Manager feedback loops: Line managers are often the most reliable signal for whether communications are landing. Structured check-ins or brief reporting templates can surface where messages are getting lost in translation.
- Comment and response rates: On platforms that allow two-way communication, the volume and tone of employee responses to leadership messages are meaningful engagement indicators.
One consideration specific to pharmaceutical companies is that employee populations are often highly segmented: field medical teams, regulatory affairs, commercial, and manufacturing all have different communication needs and consumption habits. Engagement data should be disaggregated by function and geography rather than reported as a single organisation-wide figure.
What role does compliance play in evaluating pharma internal comms?
Compliance is both a goal and a measurement lens for internal communications in pharma. When employees receive, understand, and act on communications about SOPs, pharmacovigilance obligations, promotional codes, or data privacy requirements, compliance outcomes improve. Conversely, compliance failures often trace back to communications that were unclear, poorly timed, or not confirmed as received.
Compliance-related measures that internal comms teams should track include:
- Confirmed receipt and acknowledgement rates for mandatory communications
- Completion rates for compliance training linked to communications campaigns
- Time-to-completion for policy updates following a regulatory change
- Audit findings that reference communication gaps or misunderstandings
Regulatory environments such as those governed by the ABPI Code in the UK, the PhRMA Code in the US, or EMA guidance in Europe create specific obligations around how information is communicated internally — particularly for promotional materials, adverse event reporting, and scientific exchange. Internal comms effectiveness in these areas cannot be assessed without reference to whether communications meet those obligations and whether employees can demonstrate that they do.
This is where internal communications in pharma diverges most sharply from other industries. Engagement is desirable; compliance is non-negotiable. Effective measurement frameworks reflect that hierarchy.
How can you tell if internal communications are driving behaviour change?
Behaviour change is the hardest outcome to attribute to internal communications, but it is also the most meaningful. You can identify genuine impact when you observe consistent shifts in how employees act — not just what they say they understand — following a communications intervention.
Indicators of genuine behaviour change include:
- Increased use of approved resources or platforms following a communications campaign promoting them
- Measurable shifts in cross-functional collaboration patterns after internal change programmes
- Reduction in non-compliance incidents following targeted awareness communications
- Faster adoption of new processes or systems when communications are structured around clear calls to action
Attribution is the central challenge. Behaviour rarely changes because of a single communication; it shifts through repeated, consistent messaging across multiple channels, reinforced by leadership behaviour. The most reliable approach is to establish a pre-campaign baseline, define specific behavioural outcomes in advance, and measure against those outcomes at agreed intervals after the campaign closes.
In pharmaceutical organisations, where scientific rigour is embedded in the culture, this kind of pre-and-post measurement design is both credible and practical. Internal comms teams that frame their measurement in these terms tend to earn more strategic influence within the organisation.
What tools do pharma companies use to track internal comms performance?
Pharma companies use a combination of dedicated internal communications platforms, broader HR and employee experience technology, and bespoke measurement tools to track performance. The right tool stack depends on the size of the organisation, the complexity of its employee population, and the channels it relies on most heavily.
Commonly used tools and platforms include:
- Intranet and digital workplace platforms: Tools such as Viva Engage, Staffbase, Simpplr, or SharePoint provide analytics on content consumption, search behaviour, and engagement patterns across the internal digital environment.
- Email analytics: Platforms like Poppulo or ContactMonkey are built specifically for internal email measurement and offer open rates, click maps, and device data at a more granular level than standard email clients.
- Survey and listening tools: Platforms such as Qualtrics, Peakon, or Glint support pulse surveys, sentiment tracking, and manager-level reporting, allowing comms teams to connect employee feedback to specific campaigns or periods.
- Learning management systems (LMS): For communications tied to training or compliance, LMS platforms provide completion data, assessment scores, and certification tracking.
The most effective pharma internal comms teams do not rely on a single tool. They build a measurement architecture that connects channel analytics to survey data to business outcomes, and review that architecture regularly to ensure it is still capturing what matters.
How often should pharma organisations review their internal comms strategy?
At minimum, annually — with lighter-touch performance reviews every quarter. Given the pace of regulatory change, pipeline developments, and organisational restructuring that characterises the pharmaceutical sector, a strategy that was fit for purpose eighteen months ago may already be misaligned with your current priorities.
A structured review cycle might look like this:
- Quarterly: Review channel performance data, pulse survey results, and any compliance-related communications incidents. Identify what is working, what is not, and where gaps are emerging.
- Annually: Conduct a full strategic review that includes employee listening sessions, stakeholder interviews, and an audit of the channel mix. Reassess whether the communications strategy supports the organisation’s current scientific, commercial, and people priorities.
- Event-triggered: Major organisational changes — a merger, a product launch, a significant regulatory development, or a leadership transition — should each prompt a targeted review of how internal communications need to adapt.
In 2026, with AI-assisted communications tools becoming more widely adopted and employee expectations around transparency continuing to rise, the frequency and depth of strategy reviews matter more, not less. Organisations that treat their internal comms strategy as a static document rather than a living framework tend to fall behind — both in employee engagement and in their ability to communicate effectively during periods of change.
How Wizzard helps pharma organisations measure and strengthen internal communications
We work with pharmaceutical and healthcare organisations to develop internal communications that are strategically grounded, scientifically credible, and measurable from the outset. For teams looking to move beyond basic analytics and build a genuine picture of internal comms effectiveness, our approach includes:
- Strategic planning that defines clear behavioural and compliance outcomes before a campaign launches
- Creative communications designed to drive comprehension and action, not just reach
- Internal communications programmes spanning digital, film, events, and leadership messaging
- Frameworks for connecting communications activity to measurable business and compliance outcomes
If you’re ready to raise the standard of your pharma employee communications programme, get in touch with Wizzard to explore what a more strategic approach could look like for your organisation.
Related Articles
- What makes internal workshops effective in pharmaceutical organisations?
- What is the difference between employee engagement and internal comms?
- How Can Digital Communications Improve Patient Engagement?
- How Should Pharma Build an Omnichannel Communications Strategy?
- How Can Digital Health Communications Improve HCP Engagement?